Key result
Indoxyl sulfate drives MR activation via oxidative stress in CKD rats, which alpha-lipoic acid attenuates.
Why the study?
Indoxyl sulfate promotes CKD progression, but its association with mineralocorticoid receptor activation remains unknown.
p-value: p=<0.01
Indoxyl sulfate enhances mineralocorticoid receptor transactivation through oxidative stress, providing a mechanistic rationale for using MR antagonists and antioxidants to inhibit CKD progression.
May support testing alpha-lipoic acid with MR antagonists in CKD; hypothesis-generating from rat model alone.
BACKGROUND: The uremic toxin indoxyl sulfate (IS) is an important factor in chronic kidney disease (CKD) progression. Inhibitors of the renin-angiotensin system and add-on therapy with mineralocorticoid receptor (MR) antagonists can help reduce proteinuria and suppress CKD progression. However, the association between IS and MR activation remains unknown. MATERIALS AND METHODS: experiments involved transfecting COS-7 cells with MR expression plasmids and MR response element-luciferase reporter plasmids. The cells were then treated with aldosterone (10⁻¹⁰ mol/L), indoxyl sulfate (IS, 500 μmol/L), and α-lipoic acid (10⁻³ mol/L). MR transcriptional activity was investigated by luciferase assays, and protein levels were measured by Western blotting. RESULTS: In the 5/6 nephrectomy model, the serum IS concentration was significantly increased; however, the plasma aldosterone levels were decreased. Immunohistochemistry showed that the expression of IS protein increased in injured tubular cells in the 5/6 nephrectomy group compared with that in the sham group. Furthermore, evaluations of serial kidney sections revealed that the expression site of IS protein was colocalized with the distal nephron, where the expression of MR protein was observed. MR-mediated transcriptional activity in COS-7 cells was increased in an aldosterone concentration-dependent manner. IS increased MR-mediated transcriptional activity and protein levels with and without aldosterone, and α-lipoic acid attenuated this increase. CONCLUSIONS: IS could enhance MR transactivation by increasing MR protein levels through oxidative stress in CKD rats, indicating that treatment with MR antagonists and antioxidants may play a permissive role in inhibiting IS-induced CKD progression.
No takes yet. Share an insight, caveat, or question.
Kudo et al. (2024) studied Chronic kidney disease (n=12). 5/6 nephrectomy (in vivo) / Indoxyl sulfate (in vitro) vs. Sham procedure (in vivo) / Vehicle (in vitro) was evaluated on Mineralocorticoid receptor transcriptional activity and protein levels (p=<0.01). Indoxyl sulfate enhanced mineralocorticoid receptor transactivation by increasing MR protein levels through oxidative stress in a chronic kidney disease rat model, an effect attenuated by alpha-lipoic acid.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: